Eye News and Research

Latest Eye News and Research

AMDAI launches 'Don't Surrender to AMD' public awareness campaign

Age-related Macular Degeneration (AMD), which affects more than 10 million older Americans, continues to be the leading cause of vision loss in the United States. The global cost of the disease according to a recent report by AMD Alliance International (AMDAI) is estimated at $343 billion, underscoring the need for swift actions to raise awareness of prevention and treatment options.

18 Sep 2010

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using Riboflavin/Dextran and Hypotonic Riboflavin in patients with progressive keratoconus and corneal ectasia.

17 Sep 2010

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.

16 Sep 2010

ISTA Pharmaceuticals initiates REMURA Phase 3 clinical program for dry eye disease

ISTA Pharmaceuticals, Inc., today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye disease. The Phase 3 efficacy studies are being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

16 Sep 2010

Retina Implant AG presents clinical data of successful subretinal electronic implants

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.

16 Sep 2010

AIAM offers Skin Sculpting Technique training with Dermasculpt smooth-tip microcannula

The latest trend among European doctors, a non-bruising & virtually painless injection technique for fillers using an FDA approved, FLEXIBLE smooth-tip 27G 1 ½" microcannula instead of a sharp needle has now made its way to this side of the Atlantic.

16 Sep 2010

Researchers develop infected tissue model for Aganocide compounds

Two common and important human pathogens, P. aeruginosa and S. aureus, are implicated in many clinical diseases of the eye and skin, including keratitis and impetigo, respectively. Infections with their associated toxins can result in the destruction of underlying tissue.

16 Sep 2010

BioResonator signs new orders for glaucoma diagnostic product distribution

BioResonator signs new orders with several new distributors. As of one month, the company has the official CE approval required to sell their products throughout the European Union.

16 Sep 2010

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

On Thursday, Sept. 16, the Stanford Cancer Center will become the first treatment center on the West Coast and the fifth in the world to offer cancer patients the TrueBeam, a machine that represents an exponential leap forward in the speed, power and precision of radiation therapy.

15 Sep 2010

EHSI applauds Sen. Specter's support for Stem Cell Research Advancement Act

Emerging Healthcare Solutions, Inc. cheered Sen. Arlen Specter's (D-Penn.) statement of support for the Stem Cell Research Advancement Act on Monday.

15 Sep 2010

Early alcohol, tobacco exposure may delay puberty in girls: Study

The list of possible health effects from an early introduction to alcohol and tobacco use has just gotten longer. A new study suggests that early drinking and smoking might delay onset of puberty in girls.

15 Sep 2010

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.

14 Sep 2010

Myopia and Glaucoma genes identified

In global studies of more than 40,000 people from countries around the world, including Australia, researchers have found the genes responsible for two of the most common eye disorders - short-sightedness or myopia and glaucoma. The scientists believe this could open new diagnostic and management options.

13 Sep 2010

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

AstraZeneca and UCL (University College London) today announced that they have entered into a collaboration to develop regenerative medicines for diabetic retinopathy (DR).

13 Sep 2010

Scientists discover gene associated with myopia

Myopia (nearsightedness) is the most common eye disorder in the world and becoming more common, yet little is known about its genetic underpinnings.Scientists at Duke University Medical Center, in conjunction with several other groups, have uncovered a gene associated with myopia in Caucasian people from several different regions, including Dutch, British and Australian subjects.

13 Sep 2010

Scientists discover SNP association with primary open-angle glaucoma risk

Scientists at deCODE genetics and academic colleagues from Iceland, China, Sweden, the UK and Australia today report the discovery of the most important single-letter variation (SNP) in the sequence of the human genome yet associated with risk of primary open-angle glaucoma. This is the most common form of glaucoma and a major cause of blindness worldwide.

13 Sep 2010

New neurological deficit behind amblyopia

Researchers at New York University's Center for Neural Science have identified a new neurological deficit behind amblyopia, or "lazy eye." Their findings, which appear in the most recent issue of the Journal of Neuroscience, shed additional light on how amblyopia results from disrupted links between the brain and normal visual processing.

10 Sep 2010

Dartmouth study says primary care not always a cure-all

A new study by Dartmouth Health Atlas researchers contends that making primary care more widely accessible -- one of the goals of the health overhaul -- won't necessarily improve the nation's health, Reuters reports. The researchers found wide variations in the quality of care that do not always match up with the level of access to physicians.

10 Sep 2010

Gates Foundation 2009 annual report released

The Bill & Melinda Gates Foundation on Tuesday released its 2009 annual report (.pdf) highlighting some of the foundation's work over the last year, the Puget Sound Business Journal reports (Holtzman, 9/7).

10 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

Eye News and Research

Latest Eye News and Research

AMDAI launches 'Don't Surrender to AMD' public awareness campaign

Cornea and Laser Eye Institute to study CXL effectiveness in keratoconus patients

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

ISTA Pharmaceuticals initiates REMURA Phase 3 clinical program for dry eye disease

Retina Implant AG presents clinical data of successful subretinal electronic implants

AIAM offers Skin Sculpting Technique training with Dermasculpt smooth-tip microcannula

Researchers develop infected tissue model for Aganocide compounds

BioResonator signs new orders for glaucoma diagnostic product distribution

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

EHSI applauds Sen. Specter's support for Stem Cell Research Advancement Act

Early alcohol, tobacco exposure may delay puberty in girls: Study

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Myopia and Glaucoma genes identified

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

Scientists discover gene associated with myopia

Scientists discover SNP association with primary open-angle glaucoma risk

New neurological deficit behind amblyopia

Dartmouth study says primary care not always a cure-all

Gates Foundation 2009 annual report released

FDA approves Abreu BTT 700 System for temperature monitoring

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in